MeadWestvaco a global leader in packaging and packaging solutions, introduced Dosepak
Express with Optilock technology, a customizable medication package that enables pharmaceutical companies to develop brand-specific adherence solutions that better fit patients’ lifestyles while also meeting regulatory requirements. MWV’s Dosepak product family offers global manufacturers the unique flexibility to implement this package with or without child-resistance features, depending on applicable regulatory requirements and manufacturer choice.
“The billboard space on Dosepak Express with Optilock technology provides a format for patient educational messaging and links to other adherence programs, which can increase opt-ins.”
Dosepak Express with Optilock technology utilizes a new advanced locking mechanism and is 23% smaller than the original Dosepak Express. This new smaller package size accommodates the same number and size of pills as the larger package. It is first being introduced at Pharma pack Europe on 12 and 13 February.
The package contains adherence-enhancing features, including an integrated calendar that allows patients to easily track their medications. The calendared blister stays attached to the outer carton for the duration of the medication regimen, enabling better pill protection as well as a daily opportunity for patient education and brand messaging. The outer carton is made of an environmentally friendly paperboard-based packaging solution that maximizes the use of recyclable materials and minimizes waste.
Graphics created with Illustrator and Photoshop. Comps created with Kodak digital proofs on SBS
paperboard. Assembled with
custom vac-form locking features and placebo-filled custom vacformed blisters.
“Among the many adherence solutions that are available to help patients take their medications as prescribed, medication packaging is unique because patients interact with it everyday of the medication use,” said Bruce Thomas, president, MWV Healthcare. “The billboard space on Dosepak Express with Optilock technology provides a format for patient educational messaging and links to other adherence programs, which can increase opt-ins.”
The development of Dosepak Express with Optilock is part of MWV’s long-standing commitment to further awareness and solutions for poor medication adherence. Research
shows that half of all patients in the United States and European Union do not take their medicines as prescribed. Poor medication adherence can lead to worsening of disease, serious and avoidable health risks, increased hospitalizations and even death. The annual cost of non-adherence in the US is estimated to be US$ 317 billion and US$ 125 billion in the EU.
Dosepak Express with Optilock technology is a part of MWV’s suite of proven adherence-enhancing solutions. The package was developed based on insights from medication adherence experts, customers and consumers and is an evolution of the original Dosepak packaging, which has been used extensively in both clinical research as well as in market.
